FDA NDA · NDA018970

LIPOSYN III 20%

Sponsor: HOSPIRA

APPLICATION

NDA018970

TYPE

NDA

ORIGINAL APPROVAL

1984-09-25

LATEST ACTION

2003-04-03

ROUTE

INJECTION

DOSAGE FORM

INJECTABLE

MARKETING STATUS

Discontinued

Products

LIPOSYN III 20%Discontinued

SOYBEAN OIL 20% · INJECTABLE · INJECTION

2003-04-03Manufacturing (CMC) · Supplement 13 · standard — Letter ↗AP

1997-11-17Manufacturing (CMC) · Supplement 10 · standardAP

1996-08-27Manufacturing (CMC) · Supplement 9 · standardAP

1991-01-04Manufacturing (CMC) · Supplement 6 · standardAP

1990-11-02Manufacturing (CMC) · Supplement 7 · standardAP

1988-03-04Manufacturing (CMC) · Supplement 5 · standardAP

1986-06-06Manufacturing (CMC) · Supplement 2 · standardAP

1986-02-22Manufacturing (CMC) · Supplement 3 · standardAP

1984-09-25Type 5 - New Formulation or New Manufacturer · Original · standardAP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.